Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro

Anti-Cancer Drugs

Volumn 23, Issue 2, 2012, Pages 213-219

  Zhang, Yi ^a   Wei, Ren Xiong ^a   Zhu, Xiao Bin ^a   Cai, Lin ^a   Jin, Wei ^a   Hu, Hao ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

apoptosis; invasion; migration; osteosarcoma; proliferation; Tanshinone IIA

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; GELATINASE A; GELATINASE B; PROTEIN BAX; PROTEIN BCL 2; TANSHINONE IIA; ABIETANE DERIVATIVE; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; HERBACEOUS AGENT; MMP2 PROTEIN, HUMAN; TANSHINONE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SALVIA MILTIORRHIZA; BONE TUMOR; CELL MOTION; CHEMICAL STRUCTURE; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG EFFECT; METABOLISM; PATHOLOGY; TIME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BONE NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DITERPENES, ABIETANE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MOLECULAR STRUCTURE; OSTEOSARCOMA; TIME FACTORS;

EID: 84855238447     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32834e5592     Document Type: Article

References (29)

1. Hauben EI, Arends J, Vandenbroucke JP, van Asperen CJ, Van Marck E, Hogendoorn PC. Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma. Eur J Hum Genet 2003; 11: 611-618. (Pubitemid 37038776)
2. Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006; 106:1154-1161.
3. Picci P. Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis 2007; 2:6.
4. Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: State of the art. Cancer Treat Rev 2006; 32:423-436. (Pubitemid 44309249)
5. Zhang B, Shi ZL, Liu B, Yan XB, Feng J, Tao HM. Enhanced anticancer effect of gemcitabine by genistein in osteosarcoma: The role of Akt and nuclear factor-kappaB. Anticancer Drugs 2010; 3:288-296.
6. Tingting R, Wei G, Changliang P, Xinchang L, Yi Y. Arsenic trioxide inhibits osteosarcoma cell invasiveness via MAPK signaling pathway. Cancer Biol Ther 2010; 10:251-257.
7. Cho HJ, Lee TS, Park JB, Park KK, Choe JY, Sin DI, et al. Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J Biochem Mol Biol 2007; 40:1069-1076.
8. Zhou L, Zuo Z, Chow MS. Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005; 45:1345-1359. (Pubitemid 41643896)
9. Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA 2008; 105:4826-4831. (Pubitemid 351753831)
10. Wang X, Wei Y, Yuan S, Liu G, Lu Y, Zhang J, et al. Potential anticancer activity of Tanshinone IIA against human breast cancer. Int J Cancer 2008; 116:799-807.
11. Su CC, Lin YH. Tanshinone II A. Inhibits human breast cancer cells through increased Bax to Bcl-xL ratios. Int J Mol Med 2008; 22:357-361.
12. Lee WY, Cheung CC, Liu KW, Fung KP, Wong J, Lai PB, et al. Cytotoxic effects of Tanshinones from Salvia miltiorrhiza on doxorubicin-resistant human liver cancer cells. J Nat Prod 2010; 73:854-859.
13. Long X, Zhang J, Zhang Y, Yao J, Cai Z, Yang P. Nano-LC-MS/MS based proteomics of hepatocellular carcinoma cells compared to Chang liver cells and Tanshinone IIA induction. Mol Biosyst 2011; 7:1728-1741.
14. Liu JJ, Zhang Y, Lin DJ, Xiao RZ, Tanshinone IIA. Inhibits leukemia THP-1 cell growth by induction of apoptosis. Oncol Rep 2009; 21:1075-1081.
15. Liu JJ, Lin DJ, Liu PQ, Huang M, Li XD, Huang RW. Induction of apoptosis and inhibition of cell adhesive and invasive effects by Tanshinone IIA in acute promyelocytic leukemia cells in vitro. J Biomed Sci 2006; 13:813-823. (Pubitemid 44900653)
16. Shan YF, Shen X, Xie YK, Chen JC, Shi HQ, Yu ZP, et al. Inhibitory effects of Tanshinone II-A on invasion and metastasis of human colon carcinoma cells. Acta Pharmacol Sin 2009; 30:1537-1542.
17. Chowdhury P, Bose C, Udupa KB. Nicotine-induced proliferation of isolated rat pancreatic acinar cells: Effect on cell signalling and function. Cell Prolif 2007; 40:125-141. (Pubitemid 46103695)
18. Albini A, Benelli R. The chemoinvasion assay: A method to assess tumor and endothelial cell invasion and its modulation. Nat Protoc 2007; 2:504-511. (Pubitemid 47040014)
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-408. (Pubitemid 34164012)
20. Bjørnland K, Flatmark K, Pettersen S, Aaasen AO, Fodstad O, Maelandsmo GM. Matrix metalloproteinases participate in osteosarcoma invasion. J Surg Res 2005; 127:151-156. (Pubitemid 41080627)
21. Li QF, Shi SL, Liu QR, Tang J, Song J, Liang Y. Anticancer effects of ginsenoside Rg1, cinnamic acid, and Tanshinone IIA in osteosarcoma MG-63 cells: Nuclear matrix downregulation and cytoplasmic trafficking of nucleophosmin. Int J Biochem Cell Biol 2008; 40: 1918-1929.
22. Shi SL, Li QF, Liu QR, Xu DH, Tang J, Liang Y, et al. Nuclear matrix protein, prohibitin, was down-regulated and translocated from nucleus to cytoplasm during the differentiation of osteosarcoma MG-63 cells induced by ginsenoside Rg1, cinnamic acid, and Tanshinone IIA (RCT). J Cell Biochem 2009; 108:926-934.
23. Jiang B, Zhang L,Wang Y, Li M,WuW, Guan S, et al. Tanshinone IIA sodium sulfonate protects against cardiotoxicity induced by doxorubicin in vitro and in vivo. Food Chem Toxicol 2009; 47:1538-1544.
24. Liu X,Wang Y, Ma C, Zhang L,Wu W, Guan S, et al. Proteomic assessment of Tanshinone IIA sodium sulfonate on doxorubicin induced nephropathy. Am J Chin Med 2011; 39:395-409.
25. Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 2011; 351:41-58.
26. Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998; 281:1312-1316. (Pubitemid 28406817)
27. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: A molecular definition. Oncogene 2004; 16:2825-2837. (Pubitemid 38638845)
28. Korpi JT, Hagström J, Lehtonen N, Parkkinen J, Sorsa T, Salo T, et al. Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma. Surg Oncol 2011; 20: 18-22.
29. Cheng YY, Huang L, Lee KM, Li K, Kumta SM. Alendronate regulates cell invasion and MMP-2 secretion in human osteosarcoma cell lines. Pediatr Blood Cancer 2004; 42:410-415. (Pubitemid 38524469)